EXAS vs WST · rev $2.76B vs P/E 35, rev $1.72B
EXACT Sciences Corporation (EXAS) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported WST revenue for 2026-06-30 was $1.72B. Net income was $292.8M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
EXAS currently screens at market cap $20.03B. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the EXAS and WST stock pages for the full models.
Not investment advice.